{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:36:01Z","timestamp":1780104961517,"version":"3.54.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ad.2022.03.030","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T02:28:25Z","timestamp":1671071305000},"page":"360-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Real-Life Experience of Secukinumab in Patients With Hidradenitis Suppurativa"],"prefix":"10.1016","volume":"114","author":[{"given":"F.J.","family":"Melgosa Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Garc\u00eda-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Geg\u00fandez Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mateu-Puchades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2022.03.030_bib0055","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaad.2019.08.089","article-title":"Hidradenitis suppurativa: current and emerging treatments","volume":"82","author":"Goldburg","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2022.03.030_bib0060","first-page":"53","article-title":"Systematic review of immunomodulatory therapies for hidradenitis suppurativa","volume":"13","author":"Lim","year":"2019","journal-title":"Biologics"},{"key":"10.1016\/j.ad.2022.03.030_bib0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/imt-2018-0090","article-title":"Biologics for hidradenitis suppurativa: an update","volume":"11","author":"W\u0142odarek","year":"2019","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ad.2022.03.030_bib0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coph.2019.04.006","article-title":"Pharmacological development in hidradenitis suppurativa","volume":"46","author":"Matusiak","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ad.2022.03.030_bib0075","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents","volume":"76","author":"Matusiak","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2022.03.030_bib0080","first-page":"260","article-title":"T helper 17 cell\/regulatory T-cell imbalance in hidradenitis suppurativa\/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities","volume":"179","author":"Melnik","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2022.03.030_bib0085","doi-asserted-by":"crossref","first-page":"e13845","DOI":"10.1111\/dth.13845","article-title":"Severe hidradenitis suppurativa successfully treated with secukinumab","volume":"33","author":"G\u0142owaczewska","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2022.03.030_bib0090","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ad.2019.07.007","article-title":"Moderate to severe hidradenitis suppurativa successfully treated with secukinumab","volume":"111","author":"Villegas-Romero","year":"2020","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.ad.2022.03.030_bib0095","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjd.17822","article-title":"Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa","volume":"181","author":"Prussick","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2022.03.030_bib0100","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1111\/jdv.16605","article-title":"Effectiveness of secukinumab in hidradenitis suppurativa: an open study (20 cases)","volume":"34","author":"Reguia\u00ef","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731022010535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731022010535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:14:32Z","timestamp":1757553272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731022010535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0001731022010535"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2022.03.030","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-Life Experience of Secukinumab in Patients With Hidradenitis Suppurativa","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2022.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}